We developed a CRISPR-Cas9- and homology-directed-repair-assisted genome-scale engineering method named CHAnGE that can rapidly output tens of thousands of specific genetic variants in yeast. More than 98% of target sequences were efficiently edited with an average frequency of 82%. We validate the single-nucleotide resolution genome-editing capability of this technology by creating a genome-wide gene disruption collection and apply our method to improve tolerance to growth inhibitors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nbt.4132 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!